Greg McKenzie & John Friend Talk team Antointte |
|
Meet UsThe team
behind the vision |
Team Antoinette was founded by her three sons John, Tom and William.
We'd love to hear from you! |
Why?Our Story
|
What?Our Mission
With one in two in their lifetime being diagnosed with cancer and the survival rate of metastatic cancer lower than 5%, Team Antoinette is funding groundbreaking research to find the answers to metastatic cancer.
|
How?Our Plan
Phase 1: Raise £35,000, of which 100% will go towards funding a Metastatic Cancer Research Project at the Imperial Centre for Translational and Experimental Medicine in London.
The Project, identified by Action Against Cancer, will result in the development of a revolutionary model to analyse cancer progression in just 36 months and cost a total of £321,183. Phase 2: Raise the remainder of the £321,183 to ensure the Project is completed. Phase 3: Unlock the answers to cancer across the spectrum by applying the findings of our pioneering research. |
ABOUT THE RESEARCH PROJECT
100% of the funds raised by Team Antoinette have contributed towards a £321,183 Project at the Imperial Centre for Translational & Experimental Medicine in London, which seeks to have the answers to metastatic cancer in just two more years.
Nina and her team have set out to develop a revolutionary analysis technique that will enable doctors to predict whether a tumour will spread, and if so, where to, and in the case of advanced cancer patients, send the disease back to an earlier stage, all the while preventing relapse.
This new technique will be combined with the development a novel tool that will mimic the mutation of individual patient's tumours, allowing for the analysis of the response to drugs and inform treatment adjustment on a personalised level at scale.
At present, it is hard to predict where and when this aggressive disease will develop into a secondary tumour, as unfortunately is so often the case, by which time the cancer has often developed resistance to treatment.
The Project will create the innovative tools and techniques needed to understand secondary tumours before they even emerge, solving this issue and giving doctors and patients the ability to definitively answer the questions that all cancer patients currently face.
Nina and her team have set out to develop a revolutionary analysis technique that will enable doctors to predict whether a tumour will spread, and if so, where to, and in the case of advanced cancer patients, send the disease back to an earlier stage, all the while preventing relapse.
This new technique will be combined with the development a novel tool that will mimic the mutation of individual patient's tumours, allowing for the analysis of the response to drugs and inform treatment adjustment on a personalised level at scale.
At present, it is hard to predict where and when this aggressive disease will develop into a secondary tumour, as unfortunately is so often the case, by which time the cancer has often developed resistance to treatment.
The Project will create the innovative tools and techniques needed to understand secondary tumours before they even emerge, solving this issue and giving doctors and patients the ability to definitively answer the questions that all cancer patients currently face.